{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:17:47Z","timestamp":1791908267719,"version":"4.3.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Although smoking is considered the main cause of chronic obstructive pulmonary disease (COPD), several other risk factors, including pulmonary tuberculosis (TB), contribute significantly to disease causation, particularly in developing countries. However, the underlying pathogenesis of TB-associated COPD (T-COPD) is unclear. Moreover, the need for prompt diagnosis and treatment of T-COPD to decrease the future burden of inflammation is underestimated. This study aimed to identify distinctive endogenous metabotypes of T-COPD, compared to smoking-associated COPD (S-COPD).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Cross-sectional metabolomic analyses and clinical examinations of serum samples were performed for three groups of 168 male subjects: T-COPD (<jats:italic>n<\/jats:italic> = 59), S-COPD (<jats:italic>n<\/jats:italic> = 70), and healthy normal controls (<jats:italic>n<\/jats:italic> = 39). To retain a broad spectrum of metabolites, we performed technically distinct analyses (global metabolomic profiling using LC-QTOFMS and targeted analyses using LC-MS\/MS).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Higher levels of IL-6 and C-reactive protein and St. George Respiratory Questionnaire scores were seen in the T-COPD group, compared to those in the S-COPD group. Global metabolomic profiling showed elevated metabolites, including arachidonic and eicosanoic acids, in the T-COPD group. Typical changes in tryptophan catabolism were observed through targeted profiling. Additionally, in the T-COPD group, kynurenine was elevated, and serotonin levels were reduced; therefore, indoleamine dioxygenase (IDO)\/tryptophan hydroxylase (TPH) activities were dysregulated. Correlation analyses showed that changes in oxylipins were positively correlated with serum levels of IL-6 and C-reactive protein.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Patients with TB-related COPD have enhanced inflammatory responses that may be linked to fatty acid pathways and tryptophan catabolism, which could be novel therapeutic targets for T-COPD.<\/jats:p>","DOI":"10.3389\/fmed.2021.619077","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:16:20Z","timestamp":1620965780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD"],"prefix":"10.3389","volume":"8","author":[{"given":"Da Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Youn","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Kook","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jeong","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"15076","DOI":"10.1038\/nrdp.2015.76","article-title":"Chronic obstructive pulmonary disease","volume":"1","author":"Barnes","year":"2015","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/COPD.S116086","article-title":"The role of tuberculosis in COPD","volume":"12","author":"Yakar","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000350917","article-title":"A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults","volume":"86","author":"Allwood","year":"2013","journal-title":"Respiration."},{"key":"B6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijid.2014.12.016","article-title":"Tuberculosis and chronic respiratory disease: a systematic review","volume":"32","author":"Byrne","year":"2015","journal-title":"Int J Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0954-6111(03)00255-5","article-title":"Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung","volume":"97","author":"Lee","year":"2003","journal-title":"Respir Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/crj.12621","article-title":"Tuberculosis associated chronic obstructive pulmonary disease","volume":"11","author":"Sarkar","year":"2017","journal-title":"Clin Respir J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2147\/COPD.S106875","article-title":"Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis\u2014limitations for the underlying COPD detection","volume":"11","author":"Radovic","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1601740","DOI":"10.1183\/13993003.01740-2016","article-title":"Metabolomics analysis identifies different metabotypes of asthma severity","volume":"49","author":"Reinke","year":"2017","journal-title":"Eur Respir J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11874","DOI":"10.1038\/s41598-018-30349-1","article-title":"Ursodeoxycholic acid improves liver function via phenylalanine\/tyrosine pathway and microbiome remodelling in patients with liver dysfunction","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/cancers11101497","article-title":"Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2147\/COPD.S163189","article-title":"Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study","volume":"13","author":"Oh","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11306-019-1494-5","article-title":"Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways","volume":"15","author":"Kim","year":"2019","journal-title":"Metabolomics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.2147\/COPD.S177371","article-title":"Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD","volume":"13","author":"Oh","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2147\/COPD.S196210","article-title":"Lipid metabolism in chronic obstructive pulmonary disease","volume":"14","author":"Chen","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1164\/rccm.201410-1771OC","article-title":"Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes","volume":"191","author":"Bowler","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/metabo9060111","article-title":"An updated overview of metabolomic profile changes in chronic obstructive pulmonary disease","volume":"9","author":"Ran","year":"2019","journal-title":"Metabolites."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbrc.2005.09.032","article-title":"Biochemical and medical aspects of the indoleamine 2, 3-dioxygenase-initiated L-tryptophan metabolism","volume":"338","author":"Takikawa","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.2147\/COPD.S107844","article-title":"Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease","volume":"11","author":"Gulcev","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jinf.2011.07.003","article-title":"Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia","volume":"63","author":"Suzuki","year":"2011","journal-title":"J Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11367","DOI":"10.1038\/s41598-019-47761-w","article-title":"SPIROMICS metabolomics study","volume":"9","author":"Labaki","year":"2019","journal-title":"Sci Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/metabo9100212","article-title":"Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD","volume":"9","author":"Naz","year":"2019","journal-title":"Metabolites."},{"key":"B25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1440-1843.2010.01749.x","article-title":"Tuberculosis, bronchiectasis and chronic airflow obstruction","volume":"15","author":"Jordan","year":"2010","journal-title":"Respirology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1038\/srep10961","article-title":"The existence of bronchiectasis predicts worse prognosis in patients with COPD","volume":"5","author":"Mao","year":"2015","journal-title":"Sci Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity."},{"key":"B29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.trsl.2016.06.007","article-title":"Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions","volume":"179","author":"Huang","year":"2017","journal-title":"Transl Res."},{"key":"B30","first-page":"S170","article-title":"Significance of the microbiome in chronic obstructive pulmonary disease","volume-title":"Ann Am Thorac Soc.","author":"Martinez","year":"2013"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e37314","DOI":"10.1371\/journal.pone.0037314","article-title":"Tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection","volume":"7","author":"Blumenthal","year":"2012","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM198910053211402","article-title":"The effect of cigarette smoking on neutrophil kinetics in human lungs","volume":"321","author":"MacNee","year":"1989","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2147\/COPD.S64135","article-title":"Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD","volume":"9","author":"de Moraes","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1164\/ajrccm.155.4.9105091","article-title":"Phagocytosis of small carbon particles (PM10) by alveolar macrophages stimulates the release of polymorphonuclear leukocytes from bone marrow","volume":"155","author":"Terashima","year":"1997","journal-title":"Am J Respir Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tube.2015.08.005","article-title":"TB meets COPD: An emerging global co-morbidity in human lung disease","volume":"95","author":"O'Toole","year":"2015","journal-title":"Tuberculosis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/thx.2008.103432","article-title":"Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD","volume":"64","author":"Cosio","year":"2009","journal-title":"Thorax."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.mayocp.2018.05.026","article-title":"COPD Guidelines: a review of the 2018 GOLD report","volume":"93","author":"Mirza","year":"2018","journal-title":"May Clin Proc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4025","article-title":"New anti-inflammatory targets for chronic obstructive pulmonary disease","volume":"12","author":"Barnes","year":"2013","journal-title":"Nat Rev Drug Discov."},{"key":"B39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3346\/jkms.2016.31.4.553","article-title":"Characteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.619077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:16:23Z","timestamp":1620965783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.619077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":39,"alternative-id":["10.3389\/fmed.2021.619077"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.619077","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"article-number":"619077"}}